Wednesday, May 05, 2021 5:14:56 PM
$NDTP made a 3 day break out run this week, and the ask ran all the way back to $5.00
Window to buy this before it runs to $100/share stock price on the SEC S-1/1-A filing is closing fast.
Biotech, 2 for 1 one special R/M to a shell is done
Small samples of what is coming
https://cdn.discordapp.com/attachments/462311906129084418/766666489167609877/Mark-Kester_Acid_Stable_Liposomal_Compositions_0140271824.pdf
https://cdn.discordapp.com/attachments/462311906129084418/766654464744357889/C6_Ceramide_Nanoliposomes_Target_the_War.pdf
We know for a fact that NDTP is bringing Dr. Mark Kester's LSD Disease Ceramide technology to NDTP because Hovis added LSD diseases to the web site 4-6 weeks before they issued the 100 Mil shares to buy most of Kestone-Nano/Mark Kester's work for about $400 Million dollars into a shell with a 292,200 share, locked float stock bound for an SEC 1-A uplist to NYSE filing.
What is LSD disease and why should you care?
Here is just one paper link on the massive DD I found on LSD diseases. Hint: It is directly part of the NTDP Brain Trauma repair plans, It seems.
https://www.mdpi.com/2077-0383/9/3/616/htm
If the filings do not drop by May 14th, May 14th will be the last day to buy before filings, as Schwab and TDA claim (if they are not lying again?)that they will not allow bids and orders for CE stocks after May 14th.
NDTP has a $500,000,000.00 market cap and the stock price is rising, so it seems no one is going to sell before May 17th, and buyers are, as of day 3 this week, raising the bids and buying on volume.
Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfun...
About two thirds of the patients affected with lysosomal storage diseases (LSD) experience neurological manifestations, such as developmental delay, seizures, or psychiatric problems. In order to develop efficient therapies, it is crucial to understand the neuropathophysiology underlying these symptoms. How exactly lysosomal storage affects biog...
https://cdn.discordapp.com/attachments/462311906129084418/819000674674933770/fj.202001669R.pdf
A Late 2020 Dr. Mark Kester, et al paper
If that is not enough, check this out:
Window to buy this before it runs to $100/share stock price on the SEC S-1/1-A filing is closing fast.
Biotech, 2 for 1 one special R/M to a shell is done
Small samples of what is coming
https://cdn.discordapp.com/attachments/462311906129084418/766666489167609877/Mark-Kester_Acid_Stable_Liposomal_Compositions_0140271824.pdf
https://cdn.discordapp.com/attachments/462311906129084418/766654464744357889/C6_Ceramide_Nanoliposomes_Target_the_War.pdf
We know for a fact that NDTP is bringing Dr. Mark Kester's LSD Disease Ceramide technology to NDTP because Hovis added LSD diseases to the web site 4-6 weeks before they issued the 100 Mil shares to buy most of Kestone-Nano/Mark Kester's work for about $400 Million dollars into a shell with a 292,200 share, locked float stock bound for an SEC 1-A uplist to NYSE filing.
What is LSD disease and why should you care?
Here is just one paper link on the massive DD I found on LSD diseases. Hint: It is directly part of the NTDP Brain Trauma repair plans, It seems.
https://www.mdpi.com/2077-0383/9/3/616/htm
If the filings do not drop by May 14th, May 14th will be the last day to buy before filings, as Schwab and TDA claim (if they are not lying again?)that they will not allow bids and orders for CE stocks after May 14th.
NDTP has a $500,000,000.00 market cap and the stock price is rising, so it seems no one is going to sell before May 17th, and buyers are, as of day 3 this week, raising the bids and buying on volume.
Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfun...
About two thirds of the patients affected with lysosomal storage diseases (LSD) experience neurological manifestations, such as developmental delay, seizures, or psychiatric problems. In order to develop efficient therapies, it is crucial to understand the neuropathophysiology underlying these symptoms. How exactly lysosomal storage affects biog...
https://cdn.discordapp.com/attachments/462311906129084418/819000674674933770/fj.202001669R.pdf
A Late 2020 Dr. Mark Kester, et al paper
If that is not enough, check this out:
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
